Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Diane Hoey"'
Autor:
Diane Hoey, Brigitte Birebent, Enkhtsetseg Purev, Sridhar Nair, Rajasekharan Somasundaram, Dorothee Herlyn, Michael J. Mastrangelo, Edith P. Mitchell, Weiping Li, Dewei Cai, Tianqian Zhang, David T. Harris, Nese Akis, Henry C. Maguire
Publikováno v:
Vaccine. 21:1601-1612
Monoclonal rat anti-idiotypic antibody (Ab2) BR3E4 mimicking the colorectal carcinoma (CRC)-associated epitope CO17-1A induced antigen-specific humoral and cellular immune responses in mice and rabbits. Ab2 BR3E4 was administered in a phase I trial t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66a2755121857fa47fc8738145ee0816
https://doi.org/10.1016/s0264-410x(02)00752-1
https://doi.org/10.1016/s0264-410x(02)00752-1
Autor:
Henry C. Maguire, Sridhar Nair, Diane Hoey, Enkhtsetseg Purev, Dewei Cai, David T. Harris, Edith P. Mitchell, Brigitte Birebent, Rajasekharan Somasundaram, Dorothee Herlyn, Michael J. Mastrangelo, Takashi Koido, Weiping Li
Publikováno v:
Journal of Cancer Research and Clinical Oncology. 127:R27-R33
The colorectal carcinoma (CRC)-associated CO17-1A/GA733 antigen (Ag) has been the target of a phase II/III randomized trial of passive immunotherapy with monoclonal antibody CO17-1A (Ab1), and phase I active immunotherapy trials with polyclonal anti-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21a0e95a5bae3bb6edad87e0c297759c
https://doi.org/10.1007/bf01470996
https://doi.org/10.1007/bf01470996
Autor:
Edith P. Mitchell, Weiping Li, Norbert Kuttner, Ellen Bloom, Diane Hoey, Dorothee Herlyn, Henry C. Maguire, Enkhtsetseg Purev, Heidi Braumüller, Hans-Günther Beger, Brigitte Birebent, C. Leeser, Ludger Staib, Michael J. Mastrangelo, David T. Harris, Rajasekharan Somasundaram
Publikováno v:
Critical reviews in oncology/hematology. 39(1-2)
The colorectal carcinoma (CRC)-associated GA733 antigen (also known as CO17-1A, KS1-4, KSA or EpCAM) has been the target of a phase II/III randomized trial of passive immunotherapy with monoclonal antibody CO17-1A and phase I active immunotherapy tri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0067845f87ec68124b5adef3f32e69a9
https://pubmed.ncbi.nlm.nih.gov/11418307
https://pubmed.ncbi.nlm.nih.gov/11418307